Delisting risk
Vaxart
Clinical-stage biotech developing oral tablet vaccines for infectious disease.
$0.5083
After-hours close+0.00 (+0.26%)
At close$0.5070(+0.74%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.31 | — | — |
| Aug 2026 | −$0.12 | −$0.06 | +50.0% |
| May 2026 | $0.02 | $0.02 | 0.0% |
| Mar 2026 | −$0.08 | $0.24 | +400.0% |
| Nov 2025 | −$0.07 | −$0.04 | +42.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.31 | — | — | $14.6M | — | — |
| Aug 6, 2026 | −$0.12 | −$0.06 | +50.0% | $26.2M | $27.2M | +3.7% |
| May 7, 2026 | $0.02 | $0.02 | 0.0% | $50.5M | $39.2M | −22.3% |
| Mar 12, 2026 | −$0.08 | $0.24 | +400.0% | $36.0M | $104.2M | +190.0% |
| Nov 13, 2025 | −$0.07 | −$0.04 | +42.9% | $36.0M | $72.4M | +101.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 13, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 20, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 13, 2024 | ||||||
| Mar 14, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 15, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 9, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 4, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 3, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 12, 2020 | ||||||
| Mar 19, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 9, 2019 | ||||||
| Feb 6, 2019 | ||||||
| Nov 9, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 15, 2018 | ||||||
| Feb 6, 2018 | ||||||
| Nov 2, 2017 | ||||||
| Aug 31, 2017 | ||||||
| May 4, 2017 | ||||||
| Feb 2, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Sep 13, 2016 | ||||||
| May 5, 2016 | ||||||
| Feb 5, 2016 | ||||||
| Nov 6, 2015 | ||||||
| Sep 11, 2015 | ||||||